Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.720
-0.080 (-2.86%)
At close: Mar 27, 2026, 4:00 PM EDT
2.839
+0.119 (4.39%)
After-hours: Mar 27, 2026, 7:30 PM EDT
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $6.23 million as of March 27, 2026. Its market cap has increased by 19.84% in one year.
Market Cap
6.23M
Enterprise Value
-1.65M
1-Year Change
19.84%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $6.23M, a decrease of -86.94%. That is a compound annual growth rate of -18.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.20M | 24.00% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 6.65M |
| Processa Pharmaceuticals | 6.46M |
| BioRestorative Therapies | 6.37M |
| XTL Biopharmaceuticals | 6.32M |
| Purple Biotech | 5.91M |
| Ernexa Therapeutics | 5.89M |
| Psyence Biomedical | 5.87M |
| Addex Therapeutics | 5.85M |